PDF) Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants
PDF] Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera - ScienceDirect
Microorganisms, Free Full-Text
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice - ScienceDirect
Viruses, Free Full-Text
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
Syncytia Formation Promotes Virus Resistance to Interferon and Neutralizing Antibodies
Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization